Background Therapies to interrupt the progression of early coronavirus disease 2019 (Covid-19)
remain elusive. Among them, convalescent plasma administered to hospitalized …

Background Therapies to interrupt progression of early COVID-19 remain elusive. Among
them, convalescent plasma in hospitalized patients was unsuccessful, perhaps because …

Metabolic syndrome (MS) is a risk factor for breast cancer (BC) that increases its aggressiveness
and metastasis. The prevalence of MS is higher in triple-negative breast cancer (TNBC)…

Bone metastasis is an incurable complication of breast cancer affecting 70–80 % of advanced
patients. It is a multistep process that includes tumour cell mobilisation, intravasation, …

Tumour cells can find in bone marrow (BM) a niche rich in growth factors and cytokines that
promote their self-renewal, proliferation and survival. In turn, tumour cells affect the …

Osteolytic bone metastasis in advanced breast cancer stages are a major complication for
patients quality life and a sign of low survival prognosis. Permissive microenvironments which …

Breast cancer is the predominant form of carcinoma among women worldwide, with 70% of
advanced patients developing bone metastases, with a high mortality rate. In this sense, the …

Chemotherapy is increasingly being administered in patients' homes, improving quality of
life and patient comfort as well as reducing use of inpatient facilities and costs. This article …

It has been described that the hematopoietic niche has to be considered as a dynamic
system that could easily behave as a tumor niche because they share many structural and …

BackgroundTherapies to interrupt progression of early COVID-19 remain elusive. Among
them, convalescent plasma in hospitalized patients was unsuccessful, perhaps because …